FDA News

FDA clears app for patients in treatment for opioid use disorder

December 10, 2018
The FDA has approved a mobile medical app that could increase the time a patient participates in an outpatient treatment program for opioid use…
In the Journals

Hospitalizations longer, costlier for children with juvenile dermatomyositis

December 10, 2018
Juvenile dermatomyositis increases patients’ hospital stays and inpatient cost of care, particularly among Hispanic and other non-white…
Meeting News

Tofacitinib does not confer meaningful increase in risk for venous thromboembolism

December 10, 2018
CHICAGO – Treatment with tofacitinib results in a numerically higher, but not statistically significant, risk for venous thromboembolism versus…
In the Journals

Vertebral fracture prevalence, incidence low in axial SpA

December 10, 2018
The prevalence and incidence of vertebral fracture is low among patients with early axial spondyloarthritis, according to recent data in the Annals
Meeting News

High BMD independently associated with knee, hip OA

December 7, 2018
CHICAGO — High estimated bone mineral density of the heel and femoral bone density were associated with an increased risk for osteoarthritis of…

Crowdsourcing Health Care: Is the Customer Always Right?

December 7, 2018
When investigating dining options in a new city or trendy neighborhood, many people first search Google Reviews or Yelp to see the reviews of…
In the Journals

Decline in lung function better predictor of mortality risk in SSc-ILD

December 6, 2018
Among patients with interstitial lung disease related to systemic sclerosis, diminished forced vital capacity and a decline in the diffusing capacity…
In the Journals

Myocardial inflammation frequent in RA, linked to disease activity

December 6, 2018
Researchers found that subclinical myocardial inflammation occurs frequently in rheumatoid arthritis, is associated with disease activity and could…
In the Journals

Lanadelumab effective against hereditary angioedema attacks

December 5, 2018
Subcutaneous lanadelumab, a monoclonal antibody drug, for 26 weeks significantly reduces attack rates of hereditary angioedema, according to data…
In the Journals

Knee pain lasting 1 year predicts faster cartilage loss, higher OA risk

December 5, 2018
Fluctuating and persistent knee pain over 1 year predicts accelerated cartilage loss as well as an increased risk for incident and progressive…
In the Journals

Outcomes after switching to Enbrel biosimilar influenced by patient-related factors

December 4, 2018
Adjusted treatment retention rates after 1 year were lower among patients who switched from etanercept to a biosimilar compared with the historic…
Meeting NewsPerspective

Emapalumab shows efficacy, safety in hemophagocytic lymphohistiocytosis

December 4, 2018
SAN DIEGO — The anti-interferon-gamma therapy emapalumab conferred an overall response rate of more than 60% in a cohort of young children with…
In the Journals

AMA: Only 15% of physicians practice telemedicine

December 4, 2018
Only 15.4% of physicians worked in practices that utilized telemedicine for patient interactions, such as diagnosing or treating patients, managing…

Pfizer initiates phase 3 trial of tofacitinib for ankylosing spondylitis

December 4, 2018
Pfizer has initiated a global phase 3 study intended to evaluate the safety and therapeutic activity of tofacitinib among adult patients with active…
Guidelines

ACR, National Psoriasis Foundation stress treat-to-target, TNF inhibitors in PsA guidelines

December 3, 2018
Physicians should use a treat-to-target approach, as well as TNF inhibitor biologics as a first-line therapy, in all patients with active psoriatic…
In the Journals

Blocker targeting microRNA-181a-5p successfully treats knee, spine OA

December 3, 2018
A blocker consisting of locked nucleic acid antisense oligonucleotides, targeting the biomarker microRNA-181a-5p, is successful in protecting…
In the Journals

Mesenchymal stem cell injection may improve outcomes in patients with knee OA

December 1, 2018
Patients with varus knee osteoarthritis who received a mesenchymal stem cell injection when undergoing high tibial osteotomy experienced improved…
Q&A With Healio Rheumatology

Augmenting the Risk: Breast Implants Linked to Rheumatic, Autoimmune Diseases

November 30, 2018
As one of the most frequently performed cosmetic surgery procedures in the United States, breast augmentation — or augmentation mammoplasty…
In the Journals

Rheumatologists should include cost, ability to pay in RA treatment discussions

November 29, 2018
Shared decision-making between rheumatologists and patients with rheumatoid arthritis can be negatively impacted by third-party insurance providers…
Meeting News

Knowledge, attitudes about prescription NSAID use for OA varies by ethnicity

November 29, 2018
CHICAGO — Hispanic patients with osteoarthritis were less likely than non-Hispanic white patients to believe that prescription NSAIDs could…